Literature DB >> 32020329

Metabolic Effect of the Hepatic Branch of the Vagal Nerve in One-Anastomosis Gastric Bypass (OAGB).

Jaime Ruiz-Tovar1, Carolina Llavero2.   

Abstract

BACKGROUND: Bariatric surgery is often performed not only to lose weight, but also to improve obesity-related comorbidities. A certain metabolic effect of the bariatric techniques has been demonstrated, as the improvement or even remission of comorbidities is patent, before having lost a relevant amount of weight. The autonomic innervation of diverse viscera by the vagus nerve has been hypothesized to participate in it. We aimed to evaluate the ponderal and metabolic impact of the preservation of the hepatic branch of the vagus in type 2 diabetic (T2D) patients undergoing one-anastomosis gastric bypass (OAGB). PATIENTS AND METHODS: We conducted a prospective study on patients with a preoperative diagnosis of morbid obesity and T2D, who underwent an OAGB. Preservation of the hepatic branch of the vagus was carried out in the first 14 patients (Group 1), whereas in another 14 patients it was sectioned. Ponderal and metabolic outcomes were assessed 1 and 2 years after surgery.
RESULTS: The length of the biliary limb was 210 cm in both groups. Postoperative BMI or excess BMI loss was not significantly different between groups. The patients included in Group 1 showed a statistically greater improvement in glycemic and lipid variables.
CONCLUSION: The preservation of the hepatic branch of the vagus in an OAGB leads to more favorable postoperative glycemic and lipid profiles.

Entities:  

Year:  2020        PMID: 32020329     DOI: 10.1007/s00268-020-05405-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  [Joint Position Statement of the SEEN-SECO-SEEDO-SED Societies on metabolic surgery for type 2 diabetes mellitus"].

Authors:  Miguel A Rubio; Susana Monereo; Albert Lecube; Joaquín Resa; Carlos Masdevall; Felipe de la Cruz Vigo; Mar Garrido; Albert Goday; Ignacio Llorente; Carlos Pesquera
Journal:  Endocrinol Nutr       Date:  2013-12

2.  Percutaneous electric neurostimulation of dermatome T7 improves glycemic profile in obese and type 2 diabetic patients. A randomized clinical study.

Authors:  Jaime Ruiz-Tovar; Carolina Llavero; Irene Ortega; María Diez; Lorea Zubiaga; Rafael Calpena
Journal:  Cir Esp       Date:  2015-02-01       Impact factor: 1.653

3.  An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension.

Authors:  Carlos Bernal-Mizrachi; Liu Xiaozhong; Li Yin; Russell H Knutsen; Michael J Howard; Joop J A Arends; Pascual Desantis; Trey Coleman; Clay F Semenkovich
Journal:  Cell Metab       Date:  2007-02       Impact factor: 27.287

Review 4.  The vagus nerve, food intake and obesity.

Authors:  Hans-Rudolf Berthoud
Journal:  Regul Pept       Date:  2008-03-25

5.  Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.

Authors:  Nian-Cun Qiu; Qin Zhang; Xin Song; Miao-E Liu; Xiao-Ke Li; Cheng-Xiang Shan; Ming Qiu
Journal:  J Surg Res       Date:  2014-03-26       Impact factor: 2.192

6.  Vagal innervation of the hepatic portal vein and liver is not necessary for Roux-en-Y gastric bypass surgery-induced hypophagia, weight loss, and hypermetabolism.

Authors:  Andrew C Shin; Huiyuan Zheng; Hans-Rudolf Berthoud
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

7.  Vagus nerve contributes to the development of steatohepatitis and obesity in phosphatidylethanolamine N-methyltransferase deficient mice.

Authors:  Xia Gao; Jelske N van der Veen; Linfu Zhu; Todd Chaba; Marta Ordoñez; Susanne Lingrell; Debby P Y Koonen; Jason R B Dyck; Antonio Gomez-Muñoz; Dennis E Vance; René L Jacobs
Journal:  J Hepatol       Date:  2014-11-27       Impact factor: 25.083

8.  GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats.

Authors:  Tohru Hira; Taisuke Mochida; Kyoko Miyashita; Hiroshi Hara
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-08-06       Impact factor: 4.052

Review 9.  Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals.

Authors:  Hideki Katagiri; Tetsuya Yamada; Yoshitomo Oka
Journal:  Circ Res       Date:  2007-07-06       Impact factor: 17.367

10.  Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass.

Authors:  Meera Shah; Jennie H Law; Francesco Micheletto; Matheni Sathananthan; Chiara Dalla Man; Claudio Cobelli; Robert A Rizza; Michael Camilleri; Alan R Zinsmeister; Adrian Vella
Journal:  Diabetes       Date:  2013-10-02       Impact factor: 9.461

View more
  3 in total

Review 1.  Areas of Non-Consensus Around One Anastomosis/Mini Gastric Bypass (OAGB/MGB): A Narrative Review.

Authors:  Mohammad Kermansaravi; Amir Hossein DavarpanahJazi; Shahab ShahabiShahmiri; Miguel Carbajo; Antonio Vitiello; Chetan D Parmar; Mario Musella
Journal:  Obes Surg       Date:  2021-02-17       Impact factor: 4.129

Review 2.  Effect of Biliopancreatic Limb Length on Weight Loss, Postoperative Complications, and Remission of Comorbidities in One Anastomosis Gastric Bypass: a Systematic Review and Meta-analysis.

Authors:  Erfan Tasdighi; Maryam Barzin; Kamal K Mahawar; Farhad Hosseinpanah; Amir Ebadinejad; Nazanin Taraghikhah; Anahita Mansoori; Alireza Khalaj; Mahtab Niroomand; Majid Valizadeh; Behnaz Abiri
Journal:  Obes Surg       Date:  2022-01-29       Impact factor: 4.129

3.  Impact of the Hepatic Branch of the Vagus Nerve Transection in Laparoscopic Sleeve Gastrectomy for Patients with Obesity and Type 2 Diabetes Mellitus.

Authors:  Akihiko Sano; Yosuke Seki; Kazunori Kasama; Taiki Nabekura; Yoshimochi Kurokawa; Yasunari Ubukata; Nobuhiro Nakazawa; Keigo Hara; Makoto Sakai; Makoto Sohda; Ken Shirabe; Hiroshi Saeki
Journal:  Obes Surg       Date:  2021-06-03       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.